Stock listing
CAPR Stock Price, News, Filings & Events — Capricor Therapeutics, Inc.
Selected listing: CAPR · NASDAQ · USD · US
This page tracks Capricor Therapeutics, Inc.'s CAPR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CAPR:NASDAQ. CAPR:NASDAQ is the stock-level entry point for investors researching Capricor Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Capricor Therapeutics, Inc. is a public biotechnology company traded under the ticker CAPR on the American stock market. The company focuses on developing innovative therapies for cardiovascular diseases and other serious conditions. With a market capitalization of approximately $1.14 billion, Capricor is positioned in the healthcare sector, aiming to advance its clinical programs and bring new treatments to patients.
- Ticker
- CAPR:NASDAQ
- Asset type
- Stock
- Market cap
- $557.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Capricor Therapeutics, Inc. CAPR:NASDAQ stock context
This page tracks Capricor Therapeutics, Inc.'s CAPR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CAPR:NASDAQ. CAPR:NASDAQ is the stock-level entry point for investors researching Capricor Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Capricor Therapeutics, Inc. is a public biotechnology company traded under the ticker CAPR on the American stock market. The company focuses on developing innovative therapies for cardiovascular diseases and other serious conditions. With a market capitalization of approximately $1.14 billion, Capricor is positioned in the healthcare sector, aiming to advance its clinical programs and bring new treatments to patients.
Latest news from Capricor Therapeutics, Inc.
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
August 24, 2026
Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 13, 2026
Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel
July 30, 2026
The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
July 29, 2026
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
June 26, 2026
Capricor Therapeutics, Inc. earnings calls
Capricor Therapeutics, Inc. (CAPR) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q1 2026 Earnings Call
May 12, 2026 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q4 2025 Earnings Call
March 12, 2026 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q3 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q2 2025 Earnings Call
August 13, 2025 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for CAPR:NASDAQ.
Capricor Therapeutics, Inc. company profile
View the public company page for Capricor Therapeutics, Inc. on 6ix.
Capricor Therapeutics, Inc. news
Read company news and market updates connected to Capricor Therapeutics, Inc..
Capricor Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Capricor Therapeutics, Inc..
Alternate listings
4LN2:GETTEX
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is CAPR:NASDAQ.
4LN2:TRADEGATE
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is CAPR:NASDAQ.
A2PLU4:LSX
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is CAPR:NASDAQ.
A2PLU4:LS
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is CAPR:NASDAQ.
CAPR:BOATS
US · USD
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is CAPR:NASDAQ.
4LN2:DUS
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is CAPR:NASDAQ.
4LN2:FWB
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is CAPR:NASDAQ.
4LN2:SWB
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is CAPR:NASDAQ.